Skip to the content
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
Menu
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
  • Contact
Menu
  • Contact

Nimble Therapeutics included among the 2022 Best Places to Work by Madison Magazine

read more
Path 3
  • News
  • September 15, 2022

Nimble Therapeutics was named a 2022 Best Place to Work by Madison Magazine! 

Administered annually, the Best Places to Work survey measures employee engagement and workplace factors like:
✔ trust in leadership
✔ team dynamics
✔ manager effectiveness
The competition honors superior organizations where cultures are thriving and employees are engaged.

Thank you to all of our employees for their honest feedback, and we look forward to continuing to be one of the Best Places to Work!

Read the article here: https://www.channel3000.com/nimble-therapeutics/

PreviousDiscovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases
NextNimble Therapeutics names Pete Gough as Chief Scientific Officer
PreviousDiscovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases
NextNimble Therapeutics names Pete Gough as Chief Scientific Officer
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact

603 Science Dr
Madison, WI, USA 53711

LinkedIn
  • Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
    Read More